Cambridge Investment Research Advisors, Inc. Acadia Pharmaceuticals Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$13.01 - $27.22 $124,141 - $259,733
-9,542 Closed
0 $0
Q4 2021

Feb 03, 2022
SELL
$16.79 - $27.09 $38,852 - $62,686
-2,314 Reduced 19.52%
9,542 $0
Q3 2021

Nov 02, 2021
SELL
$15.78 - $24.77 $3,156 - $4,954
-200 Reduced 1.66%
11,856 $0
Q2 2021

Aug 10, 2021
SELL
$19.4 - $27.42 $5,703 - $8,061
-294 Reduced 2.38%
12,056 $0
Q1 2021

May 07, 2021
BUY
$25.02 - $54.99 $308,997 - $679,126
12,350 New
12,350 $0

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email